伊比利亚-拉丁美洲急性胰腺炎指南(iLATAM-AP)
该指南由伊比利亚半岛与拉丁美洲多学科专家团队制定,针对急性胰腺炎管理问题在 PubMed、Embase 和 Cochrane 图书馆进行系统检索,聚焦 1979 年 1 月至 2024 年 3 月发表的随机对照试验和系统评价,证据不足时扩展至观察性研究。推荐采用 GRADE 系统制定并经专家组共识,共形成 20 条证据推荐,覆盖定义、诊断标准、病因评估、初始管理、局部并发症、内脏静脉血栓、腹腔间隔室综合征、ICU 入住指征、抗生素使用、早期 ERCP、胆囊切除时机、胆总管结石检测策略及胰腺功能不全管理。这是首个伊比利亚-拉丁美洲急性胰腺炎临床实践指南,旨在整合内科、内镜和外科方法,促进不同医疗环境下一致的高质量诊疗。
要点
- 指南共形成 20 条证据推荐,每条含推荐陈述、证据水平、推荐强度和证据摘要,采用 GRADE 系统并经专家共识制定。
- 推荐覆盖急性胰腺炎定义、诊断标准、病因评估、初始管理、局部并发症、内脏静脉血栓和腹腔间隔室综合征。
- 推荐还覆盖 ICU 入住指征、抗生素使用、早期 ERCP、胆囊切除时机、胆总管结石检测策略和胰腺功能不全管理。
- 系统检索 PubMed、Embase 和 Cochrane 图书馆,聚焦 1979 年 1 月至 2024 年 3 月发表的随机对照试验和系统评价,证据不足时纳入观察性研究。
- 这是首个伊比利亚-拉丁美洲急性胰腺炎临床实践指南,目标是在不同医疗环境下推广一致的高质量诊疗。
适用人群与场景
- 急性胰腺炎患者,包括轻症和复杂病例,适用于伊比利亚-拉丁美洲不同医疗环境。
研究设计与关键结果
- 该指南由伊比利亚半岛和拉丁美洲专家团队制定,每个问题由一名协调员和四名胰腺病学专家组成团队负责。
- 针对每个问题在 PubMed、Embase 和 Cochrane 图书馆进行系统检索,聚焦 1979 年 1 月至 2024 年 3 月以英语、西班牙语或葡萄牙语发表的随机对照试验和系统评价,无高质量证据时扩展至观察性研究。
- 推荐采用 GRADE 系统制定并提交专家组共识,未解决的问题经修订后重新提交直至达成共识。
- 共制定 20 条证据推荐,每条包含推荐陈述、证据水平、推荐强度和证据摘要。
证据类型、等级与局限
- 证据类型:临床实践指南,采用 GRADE 系统分级并经过专家共识。
- 检索聚焦随机对照试验和系统评价,无高质量证据时扩展至观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该指南为伊比利亚-拉丁美洲急性胰腺炎诊疗提供首个区域性循证推荐框架,整合内科、内镜和外科方法。
- 原文未据此给出具体床旁操作推荐。
指南或共识出处
- 指南名称:iLATAM-AP(AEG-AESPANC-OPGE-SIED-SPG Ibero-Latin American Guidelines on Acute Pancreatitis),发布机构:AEG、AESPANC、OPGE、SIED、SPG,发表于 United European Gastroenterol J。
- 方法学方案于 2022 年 7 月 23 日在 PROSPERO 注册(注册号 CRD42022345788)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Acute pancreatitis (AP) is a major cause of gastrointestinal hospitalizations worldwide. Although typically self-limiting, up to one-third of cases develop complications associated with increased morbidity and mortality. Despite recent advances that have improved outcomes, clinical heterogeneity necessitates updated, evidence-based guidance. In addition, there remains a need to improve the implementation of evidence-based recommendations across Ibero-Latin American countries by bringing together diverse scientific societies and regional experts to enhance applicability and the dissemination of best practices. This guideline offers comprehensive recommendations for both mild and complicated AP diagnosis and management.
METHODS: Questions on AP management were addressed by expert teams comprising one coordinator and four pancreatology specialists from the Iberian Peninsula and Latin America. For each question, a systematic review was conducted using PubMed, Embase, and the Cochrane Library, focusing on randomized controlled trials and systematic reviews published between January 1979 and March 2024 in English, Spanish, or Portuguese. In the absence of high-quality evidence, the search was expanded to include observational studies. Recommendations were formulated using the GRADE system and submitted to an expert panel for consensus; unresolved questions were revised and resubmitted until consensus was reached.
RESULTS: Twenty evidence-based recommendations were developed, addressing key aspects of AP management, including definitions, diagnostic criteria, etiological assessment, initial management, management of local complications, splanchnic vein thrombosis, abdominal compartment syndrome, indications for intensive care admission, antibiotic use, early endoscopic retrograde cholangiopancreatography, timing of cholecystectomy, strategies for detecting choledocholithiasis, and the management of pancreatic function insufficiency. Each recommendation included a statement, the level of evidence, the strength of the recommendation, and a summary of the supporting evidence.
CONCLUSION: The iLATAM guidelines are the first Ibero-Latin American clinical practice guidelines for AP. They provide evidence-based recommendations integrating medical, endoscopic, and surgical approaches, with the aim of promoting consistent, high-quality care across diverse healthcare settings.
TRAIL REGISTRATION: In alignment with international standards for transparency and methodological rigor, the methodological protocol for this guideline was registered in PROSPERO (International Prospective Register of Systematic Reviews) on July 23, 2022 (Registration ID: CRD42022345788).
参考来源
- Cárdenas-Jaén K, Guilabert L, Martínez-Moneo E, et al. AEG-AESPANC-OPGE-SIED-SPG Ibero-Latin American Guidelines on Acute Pancreatitis (iLATAM-AP). United European Gastroenterol J. 2026. PMID: 42216617. doi:10.1002/ueg2.70190
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。